ARTIVION (NYSE: AORT) CAO logs tax-cover stock sales and new grant

Rhea-AI Filing Summary

ARTIVION, INC. executive Amy Horton, VP and Chief Accounting Officer, reported both stock sales and a stock grant. On February 23, 2026, she sold 1,731 shares of common stock at $37.588 per share, and on February 24, 2026, she sold 830 shares at $35.693 per share.

According to the footnotes, both sales were automatic "sell to cover" transactions to pay tax withholding upon vesting of performance and restricted stock units, and did not represent discretionary trades. Horton also received a grant of 5,658 shares of restricted stock at no cost, which vest in three equal annual installments, and held 133,155 shares directly after these transactions.

Insider Trade Summary

Net Seller: 2,561 shares ($94,690)

Net Sell 3 txns

Insider Horton Amy

Role VP, Chief Accounting Officer

Sold 2,561 shs ($95K)

Type	Security	Shares	Price	Value
Sale	Common Stock	830	$35.693	$30K
Grant/Award	Common Stock	5,658	$0.00	--
Sale	Common Stock	1,731	$37.588	$65K

Holdings After Transaction: Common Stock — 127,497 shares (Direct)

Footnotes (1)

1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Horton Amy

(Last) (First) (Middle)

ARTIVION, INC.

1655 ROBERTS BLVD, NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		S		1,731(1)	D	$37.588	128,327	D
Common Stock	02/24/2026		S		830(2)	D	$35.693	127,497	D
Common Stock	02/24/2026		A		5,658(3)	A	$0	133,155	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

2. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

3. Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ Amy Horton	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Amy Horton report for ARTIVION (AORT)?

Amy Horton reported two stock sales and one stock grant. She sold 1,731 shares at $37.588 and 830 shares at $35.693, and received 5,658 restricted shares that vest over three years under the company’s Equity and Cash Incentive Plan.

Were Amy Horton’s ARTIVION (AORT) stock sales discretionary trades?

The reported stock sales were not discretionary trades. Footnotes state the 1,731 and 830 share sales were "sell to cover" transactions executed upon vesting of stock units solely to pay tax withholding obligations, rather than elective open-market sales for investment purposes.

How many ARTIVION (AORT) shares did Amy Horton sell and at what prices?

Amy Horton sold a total of 2,561 ARTIVION common shares. She sold 1,731 shares on February 23, 2026 at $37.588 per share and 830 shares on February 24, 2026 at $35.693 per share, both to cover tax withholding.

What stock award did Amy Horton receive from ARTIVION (AORT)?

She received a grant of 5,658 shares of restricted common stock at $0.00 per share. The award vests 33 1/3% per year starting on the first anniversary of the grant date, under ARTIVION’s Equity and Cash Incentive Plan terms.

How many ARTIVION (AORT) shares does Amy Horton own after these transactions?

Following the reported transactions, Amy Horton directly owned 133,155 ARTIVION common shares. This balance reflects the automatic tax-related sales, the new restricted stock grant, and prior holdings as of the dates shown in the Form 4 filing.

What does a "sell to cover" transaction mean in ARTIVION (AORT) insider filings?

A "sell to cover" transaction is when shares are automatically sold upon vesting to pay tax withholding. In this ARTIVION filing, the 1,731 and 830 share sales were executed solely to satisfy tax obligations, as detailed in the Form 4 footnotes.